Literature DB >> 17482553

An evolutionarily conserved mechanism for microRNA-223 expression revealed by microRNA gene profiling.

Taro Fukao1, Yoko Fukuda, Kotaro Kiga, Jafar Sharif, Kimihiro Hino, Yutaka Enomoto, Aya Kawamura, Kaito Nakamura, Tsutomu Takeuchi, Masanobu Tanabe.   

Abstract

Many microRNAs (miRNAs) are evolutionarily conserved and have intriguing expression patterns. Tissue and/or time-specific expressions of some miRNAs are presumably controlled by unique cis-acting regulatory elements that coevolved with the miRNA sequences. Exploiting bioinformatics, we identified several miRNAs whose primary transcripts could be regulated by conserved genomic elements proximal to their transcription start sites. Such miRNAs include microRNA-223 (miR-223), which is reportedly controlled by a unique regulatory mechanism during granulopoiesis. Here, we define a mechanism distinct from that previously proposed to regulate miR-223 expression. We find that the mir-223 gene resembles a "myeloid gene" and might be driven by the myeloid transcription factors, PU.1 and C/EBPs. This mechanism is specified by the conserved proximal cis-regulatory element and might be common among different species. Hence, it needs to be considered that two distinct mechanisms that would play critical roles in myeloid functions and differentiation are actually concerned with the regulation of miR-223.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17482553     DOI: 10.1016/j.cell.2007.02.048

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  151 in total

1.  Selective upregulation of microRNA expression in peripheral blood leukocytes in IL-10-/- mice precedes expression in the colon.

Authors:  Jeremy S Schaefer; Dina Montufar-Solis; Nadarajah Vigneswaran; John R Klein
Journal:  J Immunol       Date:  2011-10-31       Impact factor: 5.422

Review 2.  MicroRNA control of bone formation and homeostasis.

Authors:  Jane B Lian; Gary S Stein; Andre J van Wijnen; Janet L Stein; Mohammad Q Hassan; Tripti Gaur; Ying Zhang
Journal:  Nat Rev Endocrinol       Date:  2012-01-31       Impact factor: 43.330

Review 3.  Regulation of mammalian microRNA expression.

Authors:  Xiaoxiao Zhang; Yan Zeng
Journal:  J Cardiovasc Transl Res       Date:  2010-02-20       Impact factor: 4.132

4.  MicroRNA miR-125a controls hematopoietic stem cell number.

Authors:  Shangqin Guo; Jun Lu; Rita Schlanger; Hao Zhang; Judy Y Wang; Michelle C Fox; Louise E Purton; Heather H Fleming; Bradley Cobb; Matthias Merkenschlager; Todd R Golub; David T Scadden
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-08       Impact factor: 11.205

Review 5.  Translating the Untranslated Region.

Authors:  Johannes Schwerk; Ram Savan
Journal:  J Immunol       Date:  2015-10-01       Impact factor: 5.422

6.  MiR-223 deficiency increases eosinophil progenitor proliferation.

Authors:  Thomas X Lu; Eun-Jin Lim; John A Besse; Svetlana Itskovich; Andrew J Plassard; Patricia C Fulkerson; Bruce J Aronow; Marc E Rothenberg
Journal:  J Immunol       Date:  2013-01-16       Impact factor: 5.422

7.  Comprehensive silencing of target-sharing microRNAs is a mechanism for SIRT1 overexpression in cancer.

Authors:  Kotaro Kiga; Yoko Fukuda-Yuzawa; Masanobu Tanabe; Shoji Tsuji; Chihiro Sasakawa; Taro Fukao
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

8.  Comprehensive analysis of microRNA expression patterns in renal biopsies of lupus nephritis patients.

Authors:  Yong Dai; Weiguo Sui; Huijuan Lan; Qiang Yan; He Huang; YuanShuai Huang
Journal:  Rheumatol Int       Date:  2008-11-08       Impact factor: 2.631

9.  microRNA Regulation and Its Consequences in Cancer.

Authors:  Sonya Parpart; Xin Wei Wang
Journal:  Curr Pathobiol Rep       Date:  2012-12-18

10.  Progressive Control of Streptococcus agalactiae-Induced Innate Inflammatory Response Is Associated with Time Course Expression of MicroRNA-223 by Neutrophils.

Authors:  Maud Deny; Marta Romano; Olivier Denis; Georges Casimir; Mustapha Chamekh
Journal:  Infect Immun       Date:  2020-11-16       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.